Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Merck & Company, Inc.
Bree Gonzales
| Feb 2, 2022
Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Press release submission
| Sep 23, 2019
MERCK: New Data at ESMO 2019 for Merck KGaA, Darmstadt, Germany, Highlight Focused Clinical Development and Commitment to Patient Care
Trending
+
Pharmaceuticals
Patient Daily
| Apr 30, 2024
Unruly Sports Parents’ Effect on Children’s Mental Health
+
Pharmaceuticals
Patient Daily
| May 1, 2024
Asthma Awareness Month: American Lung Association Focuses on Addressing Challenges of Extreme Heat and Asthma
+
Technology/Innovation
Patient Daily
| Apr 30, 2024
Co-founder of Binance: Medical research is currently 'too profit driven'
+
Pharmaceuticals
Patient Daily
| May 2, 2024
South Florida Turns Turquoise for Lung Cancer Action Week